<DOC>
	<DOCNO>NCT01821274</DOCNO>
	<brief_summary>The purpose study determine whether Diltiazem Hydrochloride 2 % Cream cause irritation skin back healthy volunteer repeat application 21-days .</brief_summary>
	<brief_title>A 21-Day Topical Safety Study Diltiazem Hydrochloride Using Cumulative Irritant Patch Test Design</brief_title>
	<detailed_description>The primary objective study determine potential Diltiazem Hydrochloride 2 % Cream cause irritation repeat topical application healthy skin human control condition . In addition , safety assess evaluation adverse event ( AEs ) report study .</detailed_description>
	<mesh_term>Diltiazem</mesh_term>
	<criteria>Are healthy male female ( confirm medical history ) Are 18 year age older In case female childbearing potential , use acceptable form birth control ( oral/implant/injectable/transdermal contraceptive , intrauterine device , condom spermicide , diaphragm spermicide , abstinence , partner 's vasectomy ) . Abstinence vasectomy acceptable female subject agree implement one acceptable method birth control lifestyle/partner change If female childbearing potential , negative urine pregnancy test ( UPT ) Screening , willing submit pregnancy test end study ( EOS ) Are free systemic dermatologic disorder , , opinion investigator , interfere study result increase risk adverse event Are skin type race , provide skin pigmentation allow discernment erythema Complete Medical Screening form well Medical Personal History form Read , understand , provide sign informed consent Have sick sinus syndrome except presence function ventricular pacemaker ( confirm via medical history Have secondor thirddegree AV block except presence function ventricular pacemaker ( confirm via medical history ) Have hypotension ( le 90 mm Hg systolic , determine perform vital sign ) Have acute myocardial infarction pulmonary congestion document xray ( confirm via medical history ) Have visible skin disease application site , opinion investigative personnel , interfere evaluation test site reaction Are willing refrain use systemic/topical analgesic aspirin ( 81 mg daily aspirin allow ) , Aleve , Motrin , Advil , Nuprin 72 hour prior Day 1 study ( occasional use acetaminophen permit ) Are use systemic/topical corticosteroid 3 week prior study , systemic/topical antihistamine 72 hour prior Day 1 study Are use medication , opinion investigative personnel , interfere study result , include antiinflammatory medication Are unwilling unable refrain use sunscreen , cosmetic , cream , ointment , lotion , similar product back study Have psoriasis and/or active atopic dermatitis/eczema Are females pregnant , plan become pregnant study , breastfeed child Have know sensitivity constituent present material evaluate Have damage skin around test site , include sunburn , excessively deep tan , uneven skin tone , tattoo , scar , excessive hair , numerous freckle , disfiguration test site Have receive treatment type internal cancer within 5 year prior study entry Have history , currently treat skin cancer Are currently participate clinical testing Have know sensitivity adhesive Have receive investigational treatment ( ) within 4 week prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>